Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06520982 · ClinicalTrials.gov registry record · Early Phase 1

Early Neurovascular Adaptations in Aging Women

A Early Phase 1 study of Aging and Women, sponsored by University of Missouri-Columbia.

Recruiting
Registry status
Early Phase 1
Development phase
64
Enrollment target
1
Study location

NCT06520982 is a Early Phase 1 study of Aging and Women that is actively recruiting participants, run by University of Missouri-Columbia. The registered enrollment target is 64 participants, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06520982, a Early Phase 1 study of Aging and Women, is actively recruiting participants, sponsored by University of Missouri-Columbia.

RECRUITING
Registry status
Early Phase 1
Development phase
64 participants
Enrollment target
1
Study location

Study Summary

Our goal is to enhance our understanding of early vascular adaptations in aging women with an emphasis on the sympathetic nervous system.

Interventions

  • DRUG Norepinephrine
  • DRUG Isoproterenol
  • DRUG Acetylcholine
  • DRUG Nitroprusside
  • DRUG Estrogen

Study Locations (1)

Missouri

  • University of Missouri-Columbia - Columbia

Trial Details

FieldValue
Enrollment Target 64 participants
Start Date 2024-09-20
Est. Completion 2028-06-30
Phase Early Phase 1

Sponsor

University of Missouri-Columbia

291 total trials

What the Registry Record Tells You About NCT06520982

The ClinicalTrials.gov registry entry for NCT06520982 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (97% lower). The listed sponsor is University of Missouri-Columbia, which has 291 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Aging appearing as the primary indexed condition, and to 5 interventions - of which Norepinephrine is the first listed.

NCT06520982 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.

Frequently Asked Questions

What is clinical trial NCT06520982 about?

NCT06520982 is a clinical study titled "Early Neurovascular Adaptations in Aging Women". Our goal is to enhance our understanding of early vascular adaptations in aging women with an emphasis on the sympathetic nervous system.

What is the current status of trial NCT06520982?

This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 64 participants. The study started on 2024-09-20. Estimated completion is 2028-06-30.

What conditions does trial NCT06520982 study?

This clinical trial studies the following conditions: Aging, Women, Blood Flow, Sympathetic Nervous System.

What interventions are being tested in trial NCT06520982?

The interventions under investigation include: Norepinephrine (DRUG), Isoproterenol (DRUG), Acetylcholine (DRUG), Nitroprusside (DRUG), Estrogen (DRUG).

Who is sponsoring clinical trial NCT06520982?

This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06520982 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Aging

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.